Osimertinib, widely known by its brand name Tagrisso, represents a major advancement in oncology. It is a highly specialized pill. Doctors prescribe it for specific types of non-small cell lung cancer. Specifically, it targets tumors with certain genetic mutations. These…
IBRUTINIB PATIENT EDUCATION | Last reviewed: June 2026 | Medical reviewer: [Salma Mamdouh Elreedy] Ibrutinib (brand name: Imbruvica) is an oral targeted therapy used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and Waldenström’s…
Mvasi, Zirabev, Alymsys, Vegzelma, Avzivi, Jobevne — and What “Biosimilar” Actually Means Patient and Caregiver Reference | Reviewed against FDA approval records and published comparative clinical trial data Last updated: June 2026 | Next scheduled review: June 2027 or upon…
A diagnosis of MASH (metabolic dysfunction-associated steatohepatitis) brings enough stress on its own. High out-of-pocket healthcare costs should not add to that burden. The FDA approved the brand-name drug Rezdiffra (Resmetirom 80 mg) in March 2024. Today, it retails for…
Medically Reviewed by: Dr. Salma Elreedy, Clinical Oncologist, Sphinx Cure Oncology Center. Fact-Checked by: Generic Oncology Editorial Team. Synthetic lethality is a genetic phenomenon where the simultaneous loss of function in two separate genes results in cell death, while the…
Protocol Overview Historically, the discipline of clinical oncology maintained a singular, aggressive focus on tumor eradication. The primary metric of success was the reduction of tumor burden, often at the severe expense of the patient’s physical and psychological tolerance. Today,…
We have moved beyond the era where cancer care was defined strictly by high-cost, exclusive branded drugs accessible only to a small percentage of the global population. Today, the focus has shifted toward the democratization of treatment through scientific advancement…
The financial burden of cancer medication costs is often described by the medical community as “Financial Toxicity.” This is not just a term for high bills; it is a clinical reality that affects how well a patient recovers. When the…
Article Overview The news of a cancer diagnosis is a life-changing event that brings immediate emotional and practical challenges. Beyond the medical complexities of the disease, the cost of treatment often becomes a primary concern for patients and their families.…
The diagnosis of cancer brings a sudden and immense weight to any family. While the primary goal is health and recovery, the conversation quickly turns to the high cost of treatment. In the medical world, the financial strain of caring…
